Topics

Companies Related to "Moderna MRNA phane Bancel 2019 Results Earnings Call" [Most Relevant Company Matches] RSS

03:06 EST 14th December 2019 | BioPortfolio

Here are the most relevant search results for "Moderna MRNA phane Bancel 2019 Results Earnings Call" found in our extensive corporate database of over 50,000 company records.

Showing "Moderna MRNA phane Bancel 2019 Results Earnings Call" Companies 1–25 of 2,400+

Extremely Relevant

Moderna, Inc.

Moderna pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. With its breakthrough platform, Moderna is creating ...


The International mRNA Health Conference

The International mRNA Health Conference brings together top scientists and professionals from all around the world to discuss the rapidly growing field of mRNA while fostering original research and product development. Alternating locations annually between Berlin, Germany and Boston, Massachusetts, the conference is a collaborative effort of CureVac AG (...

Relevant

Moderna Therapeutics

Moderna is pioneering messenger RNA Therapeutics™, an entirely new in vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. This breakthrough platform addresses currently undruggable targets and offers a superior alternative to exi...


PRTM

PRTM has followed one principle since our founding in 1976—to make a lasting difference for our clients. The only way we can get those kinds of results is to work relentlessly and passionately as a global team with our clients.What does that mean? It means we offer insights with the power to transform the very way a company operates. We live and breathe your ecosystem, your business, your operat...

Mirrx Therapeutics

Mirrx Therapeutics is developing a novel microRNA-blocking technology, Blockmirs, which are antisense oligonucleotides that bind to a microRNA binding site on an mRNA. This unique approach blocks single microRNA:mRNA interactions, resulting in extremely targeted regulation of specific mRNAs, thereby potentially reducing unintended effects on gene activity....

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide ...

Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical stage biopharmaceutical company focused on providing administration of therapeutics to patients using its intracutaneous delivery system, which consists of titanium microneedles coated with drug that can enable rapid systemic administration to patients. The company’s lead product candidate is QtryptaTM (M207), w...

Capital Earnings & Research

Gene Tools LLC

Gene Tools is the sole commercial supplier for research quantities of Morpholino antisense oligos world-wide. Our Morpholino oligos are the premier tools for gene knockdown in developmental biology labs and are the best gene-silencing reagents for cells in culture. Morpholino oligos are short chains of Morpholino subunits comprised of a nucleic acid base, a morpholine ring and a non-ionic phosphor...

Cellular Research, Inc.

Cellular Research, Inc. is a biotechnology research and development company founded by innovators from Silicon Valley and Stanford University whose mission is to develop revolutionary quantitative biology products. Cellular Research is commercializing research products (including Pixel™, a standalone direct mRNA quantitation platform, and Preciseâ„...

Intelemedia

Intelemedia improves sales results and enhances customer experience for clients by offering a new breed of call center services that combines an industry-leading technology platform uniting top performing agents from multiple call center companies. One contract, one platform, one invoice makes it easy for companies who want actionable reporting and analyti...

BioGenex Laboratories

BioGenex is a post-genomics era leader and pioneer in the industrial scale automation of in situ measurement and characterization of minute changes in DNA, mRNA, protein and cell/tissue morphology, an analysis used across drug discovery, drug development, and diagnostic processes.BioGenex has developed state-of-the art platform technologies to solve many of the challenges faced by post-genomic era...

Ballantyne Strong, Inc.

http://www.strong-world.com (Investor Relations section) or www.earnings.com

Affluent Medical

Results have been presented Saturday February 9th, 2019 at Controversies And Updates in Vascular Surgery congress (CACVS) in Paris by Professor Dominique Fabre, MD, principal investigator. Study contributors are Frederic Cochennec, MD, Claude Angel, MD, Eric Allaire, MD, Philippe Brenot, MD, Riyad Bourkaib MD, Jean-Yves Riou, MD, Pascal Desgranges, MD, Ben...

Stemgent, Inc.

Stemgent, Inc. develops and markets proprietary tools and services to advance the application of human cells in biomedical research and drug discovery. The company works alongside some of the world’s leading stem cell researchers in developing innovative technologies and services to support and simplify human cell reprogramming, growth, and differenti...

Ribozyme Pharmaceuticals Incorporated

Ribozyme Pharmaceuticals was founded to develop commercial products and services based upon the significant potential of "ribozymes," a discovery of Professor Thomas R. Cech for which he shared a Nobel Prize. Ribozymes, a form of ribonucleic acid ("RNA"), can selectively inhibit the protein production and genetic function associated with a specific messenger RNA ("mRNA") molecule by binding with ...

ASPIRE 2019 Congress

Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-based technologies, such as antisense. Very little was known about antisense when the Company was first established, but its founders envisioned an opportunity to revolutionize the pharmaceutical indus...

Noveome Biotherapeutics, Inc.

Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues. Noveome’s multi-target platform biologic and lead product, ST266, is a complex, non-cellular product containing hundreds of biologically acti...

DaVita Labs

DaVita Labs, a division operating within DaVita Inc., provides quality, on-time, accurate results to help effectively identify and manage kidney patients across the nation. As a cutting-edge chronic kidney disease (CKD) specialty laboratory, DaVita Labs features the latest in end stage renal disease-specific methodology and technology for delivering quality ...

Hinduja Global Solutions

A global leader in business process management (BPM) and optimizing the customer experience lifecycle, HGS is helping make its clients more competitive every day. HGS combines technology-powered services in automation, analytics and digital with domain expertise focusing on back office processing, contact centers and HRO solutions to deliver transformational impact to clients. Part of the multi-b...

Dynal AS

Dynal developers of Dynabeads, magnetic beads for efficient and quick separation of cells, bacteria, proteins, subcellular compartments, mRNA and DNA.

Probably Relevant

FUJIFILM Irvine Scientific, Inc.

2. Date of change: January 1, 2019 in the United States

Pennsylvania Association of Staff Nurses and Allied Professionals (PASNAP)

For: June 27, 2019

Karuna Pharmaceuticals, Inc.

Karuna is a clinical-stage drug development company targeting muscarinic cholinergic receptors for the treatment of psychosis and cognitive impairment across central nervous system (CNS) disorders, including schizophrenia and Alzheimer’s disease, as well as pain. Karuna’s lead product candidate, KarXT (Karuna-Xanomeline-Trospium), is being evalua...


More From BioPortfolio on "Moderna MRNA phane Bancel 2019 Results Earnings Call"

Quick Search

Corporate Database Quicklinks